Ahmad Abbas

Dr. Ahmad Abbas


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2021 in Turkish Thoracic Journal
Verified
Journal Article
Closed access
AAAhmad Abbas
Ahmad Abbas
TATorki Al-Otaibi
Torki Al-Otaibi
OGosama Gheith
osama Gheith
ANAyman Maher Nagib
Ayman Maher Nagib
MFMahmoud M. Farid
Mahmoud M. Farid
MWMohammad Walaa
Mohammad Walaa
COVID-19,medical errors,sleep quality

1 May 2018 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
AAAhmad Abbas
Ahmad Abbas
SESameh Embarak
Sameh Embarak
MWMohammad Walaa
Mohammad Walaa
SLSamah Mohamed Lutfy
Samah Mohamed Lutfy
Background: The diaphragmatic rapid shallow breathing index (D-RSBI), which is the ratio between respiratory rate (RR) and the ultrasonographic evaluation of diaphragmatic displacement (DD), is a new and promising tool to predict weaning outcome. Its accuracy in predicting weaning failure, in ready-to-wean acute exacerbation COPD (AECOPD) patients, needs to be evaluated. Patients and methods: A prospective observational study was carried out on ready-to-wean AECOPD patients. During a T-tube spontaneous breathing trial (SBT) evaluation of the right hemidiaphragm displacement (ie, DD), M-mode ultrasonography to calculate the D-RSBI, as well as the RSBI (RR/tidal volume [VT]) were carried out simultaneously. Outcome of the weaning trial was recorded. Receiver operating characteristic (ROC) curves were used to evaluate the diagnostic accuracy of D-RSBI and RSBI. Results: A total of 50 AECOPD patients requiring mechanical ventilation for more than 48 h who were ready to perform a SBT were included. Of these, 37 (74%) were successfully liberated from mechanical ventilation. Among the 13 patients who failed the weaning trial, 8 (62%) failed the SBT and reconnected to the ventilator, 2 (15%) were reintubated within 48 h of extubation and 3 (23%) required NIV support within 48 h of extubation. The areas under the ROC curves for D-RSBI and RSBI were 0.97 (p<0.001) and 0.67 (p<0.06), respectively. Conclusion: D-RSBI (RR/DD) is superior to the traditional RSBI (RR/VT) in predicting weaning outcome in AECOPD patients.

19 February 2022 in The Egyptian Journal of Bronchology
Verified
Journal Article
Open access
PDF file
NZNiveen E. Zayed
Niveen E. Zayed
AAAhmad Abbas
Ahmad Abbas
SLSamah Mohamad Lutfy
Samah Mohamad Lutfy
The challenge in treating severe COVID-19 in the absence of targeted medication is enforcing physicians to search carefully for clinical predictors of severity. To define the profile of patients at risk of severe COVID-19 and to assess for certain predictors. Confirmed COVID-19 cases were classified into the following: group A: mild/moderate cases and group B: severe/critical cases according to the selected criteria. History, radiological assessment, complete blood count, lactate dehydrogenase (LDH), myocardial enzymes, serum ferritin, and D dimer were assessed. Patients were followed for the need of ICU and mechanical ventilation. Duration till conversion, length of stay, and mortality were recorded. A total of 202 patients were analyzed. Group B had higher age (53.2 ± 12.6 vs 40.3 ± 10.3, P < 0.001), more prevalence of DM (60.61% vs 16.57% P < 0.001), hypertension (51.52% vs 20.12%, P < 0.001), ischemic heart (27.27% vs 3.55%, P < 0.001), bronchial asthma (36.36% vs 3.55%, P < 0.001), COPD (9.09% vs 1.18%, P = 0.03), higher mean platelet volume (MPV) (12.76 ± 7.13 vs 10.51 ± 7.78 (fL), P < 0.001), higher serum ferritin (954 ± 138 vs 447 ± 166 ng/ml, P < 0.001), higher LDH (604 ± 220 vs 384 ± 183 U/L, P-value < 0.001), higher creatine phosphokinase (24.27 ± 5.82 vs 16.4 ± 4.87 IU/L, P < 0.001), and higher mortality (30.3% vs 0.6%, P < 0.001). Multivariate regression of predictors of severity identified three predictors; age, MPV, serum ferritin, and IHD. The current study places of interest the characteristic host-related features of severe COVID-19 and draws attention to potential predictors.

1 May 2019 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
MFMaha Fathy
Maha Fathy
AAAsmaa Ali
Asmaa Ali
AAAhmad Abbas
Ahmad Abbas
MAMohammad Shafiq Awad
Mohammad Shafiq Awad
MGMohammad Gouda
Mohammad Gouda
ASAmany M. Sediq
Amany M. Sediq
Background: Pulmonary hypertension (PH) is one of the most common complications developed during the course of chronic obstructive pulmonary disease (COPD). Platelet activation plays an important role in its pathophysiology, and mean platelet volume (MPV) is considered a respectable index of platelet activation. The aim of this work is to assess the ability of MPV in predicting PH secondary to COPD as well as its severity. Methods: A cross-sectional study was conducted on 228 stable COPD patients. CBC, echocardiography, and pulmonary function tests were performed. Results: The prevalence of PH in stable COPD patients was high (63%), and the majority of patients had a mild degree (33%). There was no significant association between PH presence with different COPD grade, but, in very severe COPD, severe PH was significantly presented. MPV in COPD patients with PH was significantly higher than those without (9.02±1.14 vs 7.11±0.98, P7.25 had 96% sensitivity and 76% specificity in predicting PH. Conclusion: MPV was higher in COPD patients with PH and positively correlated with PH severity. If the data are to be confirmed, MPV may be taken into consideration in decision-making and management of COPD patients.

1 January 2019 in The Egyptian Journal of Chest Diseases and Tuberculosis
Verified
Journal Article
Open access
AAAhmad Abbas
Ahmad Abbas
SLSamahM Lutfy
SamahM Lutfy
Exist regarding outcomes. This study aimed at defining risk factors associated with UE with respect to consequences in relation to reintubation and mortality. Patients and methods Invasively mechanically ventilated patients were enrolled and classified into planned extubation and UE groups according to the type of extubation. All patients were subjected to calculation of Simplified Acute Physiology Score on admission and Glasgow Coma Score, observed for presence of agitation, wrist restrains, use of sedation, and degree of sedation using Ramsay Sedation Score. Duration of mechanical ventilation before UE, patient-to-nurse ratio, timing of UE, total ICU length of stay, and mortality were recorded. Satisfaction question was applied to both responsible nurse and resident. Results Overall, 11.02% of the studied patients experienced UE. UE was more prevalent in patients who were physically restrained, agitated, less sedated, with lower Ramsay score, and with unsatisfied loaded nurses and junior resident who were unsatisfied. In all, 55.6% of UE occurred in night shifts. UE had prolonged length of stay (13.28±3.92 days), higher reintubation rate (44.5%), and higher mortality (29.6%). Conclusion This work identified four independent risk factors for UE: agitated patient, managed by a junior resident and loaded nurse particularly in a night shift....

29 September 2021 in Advanced Pharmaceutical Bulletin
Verified
Journal Article
Closed access
HDHayder Kadhim Drais
Hayder Kadhim Drais
AAAhmad Abbas
Ahmad Abbas
Purpose: Felodipine, is a calcium-channel antagonist used for hypertension and angina pectoris. It is practically insoluble in aqueous media and shows low oral bioavailability (15%-20%). This investigation aims to prepare and characterize oral felodipine lipid-polymer hybrid nanocarriers (LPHNs) to increase solubility and control delivery for increasing bioavailability and enhance patient compliance. Methods: The newly microwave-based method was prepared with felodipine LPHNs (H1-H35) successfully. The (H1-H35) were subjected to thermodynamic stability experiments. After that, select nine felodipine LPHNs (F1-F9) that have smart physical stability for further optimization of different characterization processes. Results: The felodipine LPHNs (F4) are considered the most optimized formula. It was characterized by lower particle size (33.3 nm), lower PDI (0.314), high zeta potential (13.6 mV), entrapment efficiency is (81.645 %w/w), drug loading is (16.329 % w/w), the pH value is 4, excellent percent of light transmittance (95.5%), pseudoplastic rheogram, significantly high (p< 0.05) dissolution rate with sustained drug delivery and success ex-vivo intestinal permeation attributes. The (F4) subject for further investigations of fourier transformed infrared spectroscopy (FTIR), atomic force microscopy (AFM), and transmission electron microscopy (TEM). The results of FTIR, AFM, and TEM indicate there is no interaction between the felodipine and excipients and that the particulate system in the nanoscale dispersion system confirms the high stability. Conclusion: The optimized felodipine LPHNs (F1-F9) formulations were smart formulations for sustained oral delivery of felodipine and that F4 was the most optimized formula according to its characterization processes.